|
CCNL1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | <1E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.83364434747091E-12 |
| Normal-vs-Stage2 |
1.802310E-04 |
| Normal-vs-Stage3 |
3.83060000386237E-08 |
| Normal-vs-Stage4 |
3.29489999995047E-06 |
| Stage1-vs-Stage2 |
6.430400E-01 |
| Stage1-vs-Stage3 |
8.918000E-01 |
| Stage1-vs-Stage4 |
9.077800E-01 |
| Stage2-vs-Stage3 |
6.216600E-01 |
| Stage2-vs-Stage4 |
6.460200E-01 |
| Stage3-vs-Stage4 |
9.980800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.45039577307216E-14 |
| Normal-vs-AfricanAmerican |
1.13179999816637E-08 |
| Normal-vs-Asian |
1.675940E-02 |
| Caucasian-vs-AfricanAmerican |
1.860110E-03 |
| Caucasian-vs-Asian |
2.790600E-01 |
| AfricanAmerican-vs-Asian |
7.103200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.52579965223754E-10 |
| Normal-vs-Female |
1.62470037423645E-12 |
| Male-vs-Female |
1.56698999999039E-05 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.262400E-02 |
| Normal-vs-Age(41-60Yrs) |
1.67854619093077E-12 |
| Normal-vs-Age(61-80Yrs) |
2.610101024203E-11 |
| Normal-vs-Age(81-100Yrs) |
4.902300E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.920300E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.542970E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.774410E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.335600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.727800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.482400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
4.025500E-04 |
| Normal-vs-Grade 2 |
5.83977310952832E-14 |
| Normal-vs-Grade 3 |
3.10889980426055E-10 |
| Normal-vs-Grade 4 |
3.447300E-04 |
| Grade 1-vs-Grade 2 |
1.217250E-01 |
| Grade 1-vs-Grade 3 |
8.063900E-03 |
| Grade 1-vs-Grade 4 |
1.233730E-02 |
| Grade 2-vs-Grade 3 |
5.784200E-02 |
| Grade 2-vs-Grade 4 |
9.386400E-02 |
| Grade 3-vs-Grade 4 |
6.371600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
3.17967874252645E-13 |
| Normal-vs-ccB subtype |
2.14209999960246E-07 |
| ccA subtype-vs-ccB subtype |
4.485600E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.18303153332045E-12 |
| Normal-vs-N1 |
4.170200E-01 |
| N0-vs-N1 |
7.378300E-02 |
|
|
